Syncona’s Autolus and BioNTech forge alliance to propel CAR-T therapies

Syncona Ltd, a prominent investor in the life sciences sector, has announced a significant strategic collaboration through its portfolio company, Autolus Therapeutics plc, with BioNTech ... Read More